Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cipla Evaluates US Portfolio Tucks, Generic Advair Studies Progress
Feb 08 2018
•
By
Anju Ghangurde
CIPLA AIMS TO MAINTAIN A HEALTHY PROFITABILITY PROFILE
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip